Burning Rock Biotech Limited reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 142.52 million compared to CNY 135.52 million a year ago. Net loss was CNY 185.25 million compared to CNY 261.39 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
8.3 USD | +3.36% | +4.67% | -10.75% |
04-02 | Earnings Flash (BNR.L) BURNING ROCK BIOTECH Posts FY23 Revenue $75.7M | MT |
04-02 | Earnings Flash (BNR.L) BURNING ROCK BIOTECH Posts FY23 Loss $-0.90 | MT |
1st Jan change | Capi. | |
---|---|---|
-10.75% | 82.38M | |
-16.99% | 8.67B | |
+64.83% | 4.25B | |
-1.10% | 2.51B | |
-10.68% | 2.47B | |
-41.76% | 2.25B | |
-9.02% | 1.91B | |
-19.62% | 1.56B | |
-39.61% | 1.19B | |
+9.54% | 1.15B |
- Stock Market
- Equities
- BNR Stock
- News Burning Rock Biotech Limited
- Burning Rock Biotech Limited Reports Earnings Results for the First Quarter Ended March 31, 2023